New data confirm rapid, unpredictable progression of severe aortic stenosis and need for urgent referral and evaluation of patients

Chicago--(business wire)--edwards lifesciences (nyse: ew) today announced new scientific evidence presented and published during the american college of cardiology's (acc) annual scientific session & expo, addressing the critical needs of patients with structural heart disease. without treatment, 1 in 10 patients experiencing symptoms of severe aortic stenosis (as) may die within five weeks. however, the symptoms of severe as can be difficult to detect and may progress rapidly and unpredict.
EW Ratings Summary
EW Quant Ranking